Literature DB >> 19273078

Cystatins and cancer.

James L Cox1.   

Abstract

Cystatins are natural cysteine protease inhibitors which belong to a superfamily of proteins with wide occurrence in tissues. The cystatins have been shown to play multiple roles in normal and disease processes. In many different cancers the cathepsins, enzymes inhibited by cystatins, are elevated and participate in tumor growth and invasion. The levels of the cystatins can vary quite widely in different cancers. Recent studies have shown cystatins can block invasion or metastasis of different cancers in experimental systems. Insights into cystatin roles in cancer have provided links to tumor development, angiogenesis, and tumor cell death in this devastating disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19273078     DOI: 10.2741/3255

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  17 in total

1.  Identification of a myeloid-derived suppressor cell cystatin-like protein that inhibits metastasis.

Authors:  Angela M Boutté; David B Friedman; Matthew Bogyo; Yongfen Min; Li Yang; P Charles Lin
Journal:  FASEB J       Date:  2011-04-25       Impact factor: 5.191

2.  Reduced fertility in vitro in mice lacking the cystatin CRES (cystatin-related epididymal spermatogenic): rescue by exposure of spermatozoa to dibutyryl cAMP and isobutylmethylxanthine.

Authors:  Kim M Chau; Gail A Cornwall
Journal:  Biol Reprod       Date:  2010-09-01       Impact factor: 4.285

Review 3.  Metastasis suppressor genes at the interface between the environment and tumor cell growth.

Authors:  Douglas R Hurst; Danny R Welch
Journal:  Int Rev Cell Mol Biol       Date:  2011       Impact factor: 6.813

Review 4.  Cathepsin B: A sellsword of cancer progression.

Authors:  Olja Mijanović; Ana Branković; Alexander N Panin; Solomiia Savchuk; Peter Timashev; Ilya Ulasov; Maciej S Lesniak
Journal:  Cancer Lett       Date:  2019-02-20       Impact factor: 8.679

Review 5.  Heterogeneity of the tumor vasculature.

Authors:  Janice A Nagy; Sung-Hee Chang; Shou-Ching Shih; Ann M Dvorak; Harold F Dvorak
Journal:  Semin Thromb Hemost       Date:  2010-05-20       Impact factor: 4.180

Review 6.  Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response.

Authors:  Oakley C Olson; Johanna A Joyce
Journal:  Nat Rev Cancer       Date:  2015-12       Impact factor: 60.716

7.  Cystatin D locates in the nucleus at sites of active transcription and modulates gene and protein expression.

Authors:  Gemma Ferrer-Mayorga; Silvia Alvarez-Díaz; Noelia Valle; Javier De Las Rivas; Marta Mendes; Rodrigo Barderas; Francesc Canals; Olga Tapia; J Ignacio Casal; Miguel Lafarga; Alberto Muñoz
Journal:  J Biol Chem       Date:  2015-09-13       Impact factor: 5.157

8.  ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis.

Authors:  Jordan M Reese; Elizabeth S Bruinsma; Adam W Nelson; Igor Chernukhin; Jason S Carroll; Ying Li; Malayannan Subramaniam; Vera J Suman; Vivian Negron; David G Monroe; James N Ingle; Matthew P Goetz; John R Hawse
Journal:  Proc Natl Acad Sci U S A       Date:  2018-09-26       Impact factor: 11.205

9.  Improved quenched fluorescent probe for imaging of cysteine cathepsin activity.

Authors:  Martijn Verdoes; Kristina Oresic Bender; Ehud Segal; Wouter A van der Linden; Salahuddin Syed; Nimali P Withana; Laura E Sanman; Matthew Bogyo
Journal:  J Am Chem Soc       Date:  2013-09-19       Impact factor: 15.419

10.  Contrasting activities of estrogen receptor beta isoforms in triple negative breast cancer.

Authors:  Shunchao Yan; Parama Dey; Yvonne Ziegler; Xin Jiao; Sung Hoon Kim; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Breast Cancer Res Treat       Date:  2020-10-01       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.